The three parties have entered into a binding agreement wherein Alexion has an exclusive option to acquire privately-held Prothelia and license Laminin-111 directly from the University of Nevada,
The company is utilizing its ProNutrein discovery platform to identify and develop protein pharmaconutrients, protein nutrients identified in food with beneficial impact in many areas of human health,
Results of the study were recently published in Molecular Cancer Therapeutics. The study, led by Dr Arnon Nagler, director of the Hematology Division and Bone Marrow Transplantation Center
The product will be produced by Axxess Pharma’s wholly-owned subsidiary, AllStar Health Brands. Axxess Pharma president Dr Daniel Bagi noted the addition of Muscle Explosion expands the potential
The patent that issues will broadly and specifically cover the company’s drug candidates, their pharmaceutical compositions, and their use for treating a number of important gastrointestinal conditions in
Sprout will resubmit the New Drug Application (NDA) for flibanserin, a once-daily treatment for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women, by the third quarter. The FDA
In connection with the filing, Arena will receive a milestone payment of $500,000 from Eisai. Arena Pharmaceuticals president and CEO Jack Lief noted with over half of adults
The clinical assets include AFN-1252, a FabI inhibitor designated by the FDA as a Qualified Infectious Disease Product (QIDP) which has successfully completed a Phase 2a study for
"We are pleased to offer patients with treatment-resistant schizophrenia a new liquid formulation of clozapine that is FDA approved to treat this difficult condition," said Bruce C. Cozadd,
As part of this multi-faceted partnership with The V Foundation, Medifast will fund research grants that explore the link between obesity and cancer and the impact of healthy
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.